Sunday, October 19, 2025

Uzbekistan receives another batch of Hepatitis C Drugs from Egypt

by WNAM:
0 comments

WNAM MONITORING: In the ongoing battle against hepatitis C, Uzbekistan has received the fourth batch of the drug “Sofosbuvir-400mg” from Egypt. The delivery, comprising 6,720 units of the medication.

This latest shipment is part of a broader agreement between the Uzbekistani and Egyptian governments to combat hepatitis C. Under the agreement, Uzbekistan is set to receive a total of 800,000 units, approximately 40 tons, of medications including Daclatasvir and Sofosbuvir against hepatitis C, as well as Entecavir against hepatitis B, by the year 2025. The total value of this agreement amounts to $4.2 million.

Throughout the year 2023, a portion of these medications, valued at $696,000, were gradually dispatched to Uzbekistan to support efforts in combating these diseases.

On February 10, 2024, Uzbekistan Airways facilitated the delivery of the fourth shipment of Sofosbuvir-400mg, designated as humanitarian aid from the Egyptian government to Uzbekistan. The medication, totaling 6,720 units, was transported from Sharm el-Sheikh to Tashkent. These medications, housed in 12 boxes, will be distributed to patients at the Research Institute of Virology under the Ministry of Health of Uzbekistan.

This humanitarian initiative stems from the agreements forged during the official visit of the President of Uzbekistan to Egypt on February 20-21, 2023.

You may also like

Focus Mode